Source BioScience

CRO (Contract Research Organization)

SourceBioscience, a GLP/GCP accredited Biotechnology company with an expertise in genomics and molecular biology/tissue pathology is offering genotyping services for patient stratification to support global clinical trials.

Mutation Testing Services
SourceBioscience provides ‘state of the art’ genomics testing and a ‘one stop shop’ for its clinical trial customers.  The company  has expanded its operating facilities, and now has 5 laboratories in Cambridge, Oxford, Nottingham, London and Dublin,  providing gene sequencing and genotyping for mutation analysis and patient stratification as well as expert pathology review and specialist tissue pathology services.. It is the biggest provider in the UK of next generation sequencing services with CsPro accreditation for excellence.
Mutation analysis tests include  K-ras, B-raf,  & EGFR using rtPCR technology, as well as a newly validated NRAS test and  PI3K by pyrosequencing.  The company can offer tailor made services to companies looking to develop and validate biomarkers for companion diagnostic use.
Source BioScience is also a provider of  drug metabolism assays such as CYPs, and kinases using ABI and Affy Chip technology. It also provides CYP2D testing using the Roche amplichip.
SourceBioscience is a global company providing worldwide support for pre-clinical and clinical trial testing in all major therapeutic areas with an expertise in oncology.  Using its new genomics facilities, the company can  offer support for development programs in early discovery for new drugs and disease targets, through to pre-clinical and clinical trial testing.  Dedicated project teams are used to streamline and facilitate the process for studies including submission  to the FDA.

Specialist Central Reference Laboratory Technologies
SourceBioscience has made considerable investment in technologies to further support  diagnostic, predictive and prognostic profiling.  A comprehensive testing service is provided for HER2 & EGFR including quantitative IHC for protein expression and FISH for assessing gene copy number and/or amplification. FISH analysis of the Topoisomerase 2a gene, as a means of assessing likely response to anthracycline agents is also offered to provide data to enhance treatment options for the patient.
Source BioScinece is a european reference laboratory for Circulating tumour cell (CTC) and Circulating Endothelial cells (CEC). Enumeration of these cells is provided as well as genomic extraction from circulating cells and ECDs. Our next generation sequencing capabilities can be used to ‘muliplex’ mutation tests which is very useful for small samples such as FNAs, as well as looking at abberant tumour signals.  IHC/FISH testing is offered to determine protein expression and increased copy numbers.

Facilitation of Patient Stratification
SourceBioscience offers mutation testing to provide data on whether a patient will respond to a drug before being entered into a clinical trial, as well as tests to measure how well a patient is responding to drug and hormone treatments. These tests are provided to support clinical and market access trials, or on a sample per sample basis to the private pathology market.

Awards, Memberships and Accreditations


  • Membership:- ASCO, AACR, UK Neqas
  • Accreditation:- GLP,GCP,CPA
  • CAP/CLIA compliance

Profiles from other companies in related areas


lucideon_logo

Lucideon

With the addition of our brand new Pharmaceutical Quality Control (QC) testing laboratories, featuring state of the art equipment and facilities and a team of experienced scientists, we now offer...
pharmaschoolmailer

PharmaSchool Limited

IntroductionPharmaSchool is one of the most well-respected clinical research training organizations in the world. Established in 2005 by industry experts our philosophy is to provide excellent training which meets customers'...

Medsearch(UK)Limited

Saving lives through medical research excellence. To achieve this we will deliver tailored high quality solutions with the help of exceptionally skilled and experienced staff for clinical trials from concept...
alta_bioscience_-_final

AltaBioscience

AltaBioscience is recognised world-wide as a leading manufacturing and analysis laboratory providing synthesis of DNA and peptides and analysis of proteins and other biochemical molecules, to researchers in academia, pharmaceuticals and the food industry.

Aeirtec

Aeirtec provides conduct of circulating and boby fluid biomarker measurement in clinical and preclinical trials and advice on biomarker design strategies. Aeirtec also provides GLP examination of candidate immunogenicity and cytokine storm...

Wickham Laboratories Ltd

As a GMP / GLP compliant laboratory with over 50 years of experience, Wickham Laboratories Ltd is an established name in the fields of pharmaceutical and medical device contract testing,...
ash_meetevnt_mark_rangeleft_col

Ashfield Meetings & Events

Ashfield meetings & events is a full-service global event management company.   Our clients range from small to large pharmaceutical, biotech, medical device and diagnostic companies in addition to associations...
md_events

MD Events

Pharmaceutical Meeting ExpertsMD Events are experts in the planning and successful delivery of events worldwide. We pride ourselves on the excellent  relationships we have established over the years with our...
EJH-long-Logo-v7

EJH Microbiology Limited

With more than 25 years of experience in the biological sciences, EJH Microbiology Ltd has a wealth of knowledge in both clinical and pharmaceutical microbiology, including Quality Assurance, method and product...
untitled

Worldwide Clinical Trials

Worldwide Clinical Trials is a global CRO providing full-service drug development services to the pharmaceutical and biotechnology industries across the full continuum – from early-phase and bioanalytical sciences through Phase...
trinity

Trinity Scientific

Trinity Scientific is the new standalone contract laboratory from the DDD group of companies, providing a wide range of analytical services to the pharmaceutical industry.Having had a frustrating time ourselves...